Results 41 to 50 of about 234 (85)

Delegation - aber richtig! [PDF]

Hemming, B, Mück, S, Heistermann, P, Droste, A   +3 more
core   +1 more source

[Patient safety-development and evaluation]. [PDF]

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
Geraedts M, Hecker R, Mühr C.
europepmc   +1 more source

Extension of Regression Discontinuity Designs (RDD) to evaluate time effects - A quasi-experimental approach using the data from the new form of care "Integrated cross-sectoral psycho-oncology (nFC- isPO)". [PDF]

PLoS One
Hagemeier A, Rosenberger KD, Hellmich M.
europepmc   +1 more source

Digital lifestyle management application (levidex) for empowerment and health behaviour change in early multiple sclerosis - Results of the randomised controlled POWER@MS1 trial. [PDF]

Mult Scler
Krause N, Derad C, von Glasenapp B, Riemann-Lorenz K, Meyer B, Asendorf T, Temmes H, van de Loo M, Gold SM, Schubert C, Stürner KH, Warnke C, Schmidt S, Friede T, Heesen C, POWER@MS1 study group.   +15 more
europepmc   +1 more source

Identifying Unmet Needs of Informal Dementia Caregivers in Clinical Practice: User-Centered Development of a Digital Assessment Tool. [PDF]

JMIR Aging
Biernetzky OA, Thyrian JR, Boekholt M, Berndt M, Hoffmann W, Teipel SJ, Kilimann I.   +6 more
europepmc   +1 more source

Increasing the effectiveness of psychotherapy in routine care through blended therapy with transdiagnostic online modules (PsyTOM): study protocol for a randomized controlled trial. [PDF]

Trials, 2022
Schaeuffele C, Heinrich M, Behr S, Fenski F, Hammelrath L, Zagorscak P, Jansen A, Pohl S, Boettcher J, Knaevelsrud C.   +9 more
europepmc   +1 more source

Meningococcal prophylaxis in neurological diseases treated with complement inhibitors: an expert consensus for Germany, Austria, and Switzerland. [PDF]

Ther Adv Neurol Disord
Berthele A, Aktas O, Ayzenberg I, Claus H, Lâm TT, Löscher WN, Pröbstel AK, Prüss H, Rademacher N, Ringelstein M, Rommer P, Schara-Schmidt U, Schoser B, Weber JR, Zschüntzsch J, Meisel A, Lünemann JD.   +16 more
europepmc   +1 more source

Unmet needs in the care of patients with neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody associated disease: insights from Germany. [PDF]

Neurol Res Pract
Giglhuber K, Bertrand A, Zappe C, Kleiter I, Ayzenberg I, Berthele A, Neuromyelitis Optica Study Group (NEMOS).   +6 more
europepmc   +1 more source

Outcomes of Early Versus Later Anticoagulation in Asian Atrial Fibrillation-Related Stroke: ELAN Subgroup Analysis. [PDF]

J Stroke
Yoshimoto T, Ihara M, Sylaja PN, Rossel JB, Fujimoto S, Iguchi Y, Parthasarthy R, Pamidimukkala V, Yakushiji Y, Iype T, Nakajima M, Khurana D, Nambiar V, Akiyama H, Toyoda K, Alonso A, Poli S, Kulyk C, Caracciolo NG, Hemelsoet D, Nunes AP, Pandian JD, Dawson J, Fischer U, Koga M.   +24 more
europepmc   +1 more source

Longterm efficacy of a patient focused intervention in patients with asplenia- a three year follow-up of the PrePPS trial. [PDF]

Infection
Camp J, Heine V, Bayrhuber M, Anka N, Glattacker M, Farin-Glattacker E, Rieg S.   +6 more
europepmc   +1 more source